General Information
Revision date
2022-11-10
Product name
DIETHOXYACETOPHENONE
1.2.1 Relevant identified uses
Industrial applications
1.2.2. Uses advised against
Product is not intended, labelled or packaged for consumer use
supplier name
Whitford Ltd.
Emergency telephone
+33 (0)3 27 14 97 00
Icons in SDS
Company Information
company name
Whitford Ltd.
e-mail address of the competent person responsible for the Safety Data Sheet
Product.Stewardship.EMEA@ppg.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Product definition
Mixture Classification according to UK CLP/GHS Eye Irrit. 2, H319
Signal word
Warning
Hazard statements
Causes serious eye irritation.
Prevention
Wear eye or face protection.
Response
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations. P280, P305 + P351 + P338, P337 + P313, P501
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to UK CLP/GHS Eye Irrit. 2, H319 The product is classified as hazardous according to UK CLP Regulation SI 2019/720 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
